Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2026-02-12 @ 12:58 PM
Study NCT ID:
NCT02499003
Status:
COMPLETED
Last Update Posted:
2022-03-31
First Post:
2015-07-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma
Sponsor:
Johannes Gutenberg University Mainz
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ETN-1 GOAL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None